Disclosures
Last updated April 5, 2026
Assessment, eligibility, and clinical relationship
The assessment and other information made available on this website do not, by themselves, create a doctor-patient relationship between you and LongView. Medical care, when provided, is delivered by US-licensed clinicians who follow clinical protocols designed for patient safety. Eligibility for medication (including GLP-1 therapies when clinically appropriate) depends on your history, applicable exclusion criteria, and an independent evaluation by a licensed clinician—not on website content or forms alone. Your responses may indicate that certain treatments are not appropriate; only a qualified clinician may determine whether you qualify for a prescription after an appropriate visit (including telehealth, where offered).
Outcomes and claims
Individual results vary based on starting weight, program adherence, side effects, and biology. Any benefits, averages, or stories on this site may reflect self-reported or aggregate experience—not results from a clinical trial that applies to you. Weight loss is not guaranteed. Medication is prescribed only when a medical provider determines it is appropriate and may not be suitable for everyone. Consult a healthcare professional before using medication or starting any weight loss program.
Compounded medications (where applicable)
If your care plan involves compounded GLP-1 medications, those products may be prepared in FDA-registered outsourcing facilities. Compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality in the same way as branded, FDA-approved drugs. The decision to use a compounded drug is made by your licensed provider based on consultation and your medical history. Discuss specific risks and benefits with your clinician. LongView does not compound medications; medication you receive may look different from what is portrayed on this website.
Branded products
Where referenced, Wegovy® is FDA-approved for chronic weight management. Ozempic® is FDA-approved for type 2 diabetes treatment and may be prescribed for weight management when clinically appropriate. Trademarks, trade names, and product marks (including Wegovy® and Ozempic®) belong to their respective owners.
Pharmacy
When prescriptions are issued, they may be filled through US-licensed pharmacies that meet applicable regulatory standards.
Artificial intelligence and marketing imagery
Certain materials on this website—including text, images, or other media—may be generated or enhanced using artificial intelligence. No representation or warranty is made regarding the accuracy, completeness, or reliability of such content. Individuals appearing in advertisements may be models or illustrative portrayals and may not be licensed medical professionals or your treating clinicians.